Diovan (valsartan) to reduce cardiovascular death after a heart attack
November 2005
Health Canada has approved Diovan (valsartan) to reduce cardiovascular death after a heart attack.
This ARB is a good choice for high-risk patients with heart failure or left ventricular dysfunction...who can't tolerate an ACEI.
Diovan seems to work as well as an ACE inhibitor for improving survival and preventing recurrent heart attacks.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive